Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

3D Bioprinting – From Science Fiction to Reality?

By IDTechEx | May 9, 2017

After more than 15 years of research and development in academia and industry, several main applications of 3D bioprinting technology are ready to be realized. In IDTechEx’s new report titled 3D Bioprinting 2017 – 2027: Technologies, Markets, Forecasts, the global 3D bioprinting market is predicted to experience a period of high growth to reach a size of $1.8 billion by the year 2027.

3D bioprinting, defined as the layer-by-layer deposition of cells to create a final 3D construct, provides users with the unique ability to create artificial tissue that closely resembles native tissue in form and function from basic biological building blocks. This biological mimicry not only enables a more efficient use of research resources by yielding physiologically relevant results, but also has applications in regenerative medicine. The latter application has long been the holy grail of 3D bioprinting technology, and promising animal trials of 3D bioprinted tissues in the past year suggest that a future where humans can replace damaged and failing organs by simply 3D bioprinting a new one may not be limited to science fiction after all.

In the short term, the next few years are set to be an exciting time of rapid expansion for the 3D bioprinting industry. Commercial interest in 3D bioprinting has risen greatly – already the first four months of 2017 has seen the release of three new affordable 3D bioprinters from manufacturers Aether, BioBots, and Cellink. Over the past year, 3D bioprinting service bureaus have experienced significant growth and are partnering with several multi-national corporations in the consumer products and pharmaceutical industries. IDTechEx report 3D Bioprinting 2017 – 2027: Technologies, Markets, Forecasts contextualises these activities, and discusses the key drivers of the 3D bioprinting industry as well as providing insight into the market trends observed.

One such market trend is the increasing versatility of 3D bioprinters. Users can now easily incorporate several 3D bioprinting technologies into their construct without involving a second or third machine. IDTechEx’s new report profiles and benchmarks the four main 3D bioprinting technologies of inkjet, extrusion, laser-induced forward transfer, and microvalve printheads. The report details key specifications, technology subtypes, and includes a SWOT analysis of each printhead technology. Alternative technologies for the creation of 3D biological structures are also introduced in the report.

3D bioprinting has applications in several high value markets, and the greatest impact of 3D bioprinting is expected to be in regenerative medicine. However, the realization of regenerative medicine solutions is not expected within the next decade. Current and future applications of 3D bioprinting covered in 3D Bioprinting 2017 – 2027: Technologies, Markets, Forecasts include the testing of cosmetics and other consumer goods, drug screening for the pharmaceutical industry, personalized medicine, regenerative medicine, cell-based biosensors, food and other animal products, education, academic research and bionics.

The recent increase in interest and excitement for 3D bioprinting bodes well for the future. In this report, IDTechEx forecasts that the overall 3D bioprinting market is set to reach $1.8 billion by the year 2027. This is driven by demand for both 3D bioprinters, and 3D bioprinted tissues, and additional 10-year forecasts for these product markets are included in the report. Though regenerative medicine is not expected to be a significant market within the next 10 years, it has and will be a major influence on the 3D bioprinting market. As such, a separate chapter of the report is dedicated to discussing the future for 3D bioprinting in regenerative medicine.

Readers of this new report by IDTechEx will gain a comprehensive view of the technologies, applications and markets of 3D bioprinting. Insights and knowledge of the industry were obtained through primary interviews with key stakeholders in 3D bioprinting companies, and these interviews also form the basis of the company profiles included at the end of the report.

For more information, go to: www.IDTechEx.com/3dbio

(Source: IDTechEx)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

This is a Hemco marketing image of its MicroFlow self-contained workstation.
Hemco highlights its self-contained workstations
Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Moving toward the autonomous lab and what’s possible today
Female worker at pharmaceutical factory operating control panel of the pharmaceutical machine.
How real-time sensors and data-savvy can cut energy waste in pharma
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE